dividend growth
Home  »  Community News  »  dividend growth
Dec
19
Ida Hansen
Royal Dutch Shell is Bullish: Should all Long Term Investors be Buying?
Blog
0
, , , , , , ,

Royal Dutch Shell (NYSE: RDS-A) is continuing to expand in areas such as Africa and the Arctic, among others, even with the falling price of oil and natural gas. The largest oil and natural gas firm in the world, Royal Dutch Shell is “Big Oil” by every meaning. But its stock price is not as […]

Dec
9
Tim Lambert
Like ExxonMobil, Chevron is Big Oil with Big Appeal for Long Term Investors
Blog
0
, , , , , , , ,

Chevron (NYSE: CVX) is like ExxonMobil (NYSE: XOM) in that it is a “Big Oil” company that has not spun off units like so many others. As a result, Chevron, again like ExxonMobil, has not fallen in recent stock market action like so many other energy companies. Chevron is down for the last week, month, […]

Dec
8
Tim Lambert
Buy Now, Don’t Try to Time Market for Stocks, Study Shows
Blog
0
, , , , , , , ,

All investors should read Dan Weiner’s article in Kiplinger’s about market timing for equities. Basically, the article states that is it best to don’t even try to time the stock market as it does not work!!! The most important lesson from the excellent piece in Kiplinger’s, which is a fine personal magazine, is to get […]

Oct
3
John Murphy
The Long Term Outlook is Still Bullish for Caterpillar
Blog
0
, , , , , , ,

Long term investing is always the best way to proceed, especially for blue chip stalwarts like Caterpillar (NYSE: CAT). For the last year of market action, Caterpillar is up over 18 percent.  But it is down for the last week, month, quarter, and six months of market action.  For 2014, Caterpillar is up around 8.6 […]

Mar
21
Ida Hansen
The Drug Industry will Gain from Globalization
Blog
0
, , , , , , , , , ,

For investors, the pharmaceutical industry and related groups is like the oil sector in that it offers a vast array of appealing stocks with a worldwide market that is growing. These range from “Big Pharma” stocks such as Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) to promising small caps such as CytoDyn Inc (NASDAQ: […]